BSESangam Health Care Products LtdHighNeutral
Announced Thu, 13 Aug, 2026 · 17:30 IST
Q1 FY27 results, MD re-appointed for 5 years
Price reaction
Awaiting price reaction for this filing.
AI summary
Board approved Q1 FY27 unaudited results. Total income rose to Rs 302.56 lakhs from Rs 281.67 lakhs in Q1 FY26. Net profit nearly tripled to Rs 30.63 lakhs from Rs 10.26 lakhs. Basic and diluted EPS stood at Rs 0.02 versus Rs 0.01 earlier. Board re-appointed Mr. Bhagat Reddy Dundumulla as Managing Director for five years effective September 5, 2026, subject to shareholder approval. Mrs. Padma Ghanakota recommended for reappointment on retirement by rotation. 32nd AGM scheduled for September 30, 2026.
Likely market impact
Profit nearly tripled year-on-year on steady revenue growth. Leadership continuity with MD re-appointment. No negative governance signals.